Next Financial Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2.13M Buy
4,548
+1,540
+51% +$663K 0.14% 160
2021
Q3
$1.28M Sell
3,008
-35
-1% -$14.8K 0.1% 222
2021
Q2
$1.09M Buy
3,043
+356
+13% +$118K 0.09% 244
2021
Q1
$758K Sell
2,687
-81
-3% -$23.2K 0.07% 299
2020
Q4
$784K Buy
2,768
+252
+10% +$70.7K 0.08% 268
2020
Q3
$692K Buy
2,516
+1,006
+67% +$266K 0.07% 259
2020
Q2
$343K Buy
1,510
+72
+5% +$14.1K 0.04% 378
2020
Q1
$219K Sell
1,438
-1,814
-56% -$279K 0.03% 503
2019
Q4
$489K Sell
3,252
-1,164
-26% -$169K 0.05% 378
2019
Q3
$627K Buy
4,416
+337
+8% +$46.4K 0.07% 311
2019
Q2
$510K Sell
4,079
-494
-11% -$58.3K 0.05% 341
2019
Q1
$504K Buy
4,573
+4,557
+28,481% +$474K 0.13% 113
2018
Q4
$2K Buy
+16
New +$1.74K ﹤0.01% 1774
2017
Q3
Sell
-200
Closed -$19K 1972
2017
Q2
$19K Buy
+200
New +$18.4K ﹤0.01% 1117
2016
Q1
Sell
-106
Closed -$6K 1884
2015
Q4
$6K Hold
106
﹤0.01% 1347
2015
Q3
$5K Hold
106
﹤0.01% 1442
2015
Q2
$6K Hold
106
﹤0.01% 1441
2015
Q1
$6K Hold
106
﹤0.01% 1447
2014
Q4
$6K Buy
+106
New +$5.3K ﹤0.01% 1448

Other funds holding WST

Next Financial Group's WST Position: Q4 2021 in Review

Next Financial Group increased its West Pharmaceutical (WST) stake by 51% in Q4 2021, buying an estimated $663K and bringing the position to 4,548 shares worth $2.13M. The position accounts for 0.14% of the portfolio, ranked #160.

Next Financial Group first reported a position in WST in Q4 2014 and has held it in 19 quarters since. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Next Financial Group held 4,548 shares of West Pharmaceutical worth $2.13M as of Q4 2021.
  • Next Financial Group bought 1,540 West Pharmaceutical shares in Q4 2021, an estimated $663K.
  • West Pharmaceutical made up 0.14% of Next Financial Group's portfolio in Q4 2021, its #160 holding.
  • Next Financial Group first reported a position in West Pharmaceutical in Q4 2014 and has held it in 19 quarters since.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.